entity

D2 autoreceptor

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about D2 autoreceptor: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
2Hypotheses
1Analyses
4Outgoing
1Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (4)

TargetRelationTypeStr
Gi/o Signalingactivatespathway0.85
cAMP Signalingregulatespathway0.85
Gi/o signalingregulatespathway0.70
RGS6regulated_byprocess0.70

Incoming (1)

SourceRelationTypeStr
RGS6associated_withprotein0.90

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Pharmacologic modulation of D2 autoreceptor-Gi/o signaling i 0.420 neurodegeneration Does RGS6 upregulation or D2 autorecepto
D2 Autoreceptor Partial Agonism as Compensatory Therapy for 0.348 neurodegeneration Does RGS6 upregulation or D2 autorecepto

Mentioning Analyses (1)

Scientific analyses that reference this entity

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

neurodegeneration | 2026-04-17 | 7 hypotheses Top: 0.559

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

While RGS6 deficiency causes Parkinson's-like pathology, whether enhancing RGS6

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Related Research

Hypotheses and analyses mentioning D2 autoreceptor in their description or question text

No additional research found